Phase I Trial of Arsenic Trioxide in Combination With Pamidronate Disodium
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Arsenic trioxide (Primary) ; Pamidronic acid
- Indications Multiple myeloma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2005 New trial record.